Avai Bio (AVAI) Gross Profit (2019 - 2023)

Avai Bio has disclosed Gross Profit across 5 years of filings, most recently posting $1.0 for Q1 2023.

• In Q1 2023, Gross Profit rose 100.0% year-over-year to $1.0; the TTM figure through Mar 2023 stood at -$40453.0 (down 105.88% YoY), while the FY2023 annual figure was -$40453.0, up 80.81% from the prior year.
• Gross Profit came in at $1.0 for Q1 2023 at Avai Bio, up from -$71537.0 in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $542902.0 in Q2 2021 to a low of -$262334.0 in Q1 2020.
• Average Gross Profit over 5 years is $51346.9, with a median of $6296.0 recorded in 2019.
• Year-over-year, Gross Profit soared 1310.52% in 2020 and slumped 206.92% in 2021.
• Over 5 years, Gross Profit stood at $6000.0 in 2019, then soared by 5669.9% to $346194.0 in 2020, then decreased by 15.66% to $291972.0 in 2021, then tumbled by 124.5% to -$71537.0 in 2022, then jumped by 100.0% to $1.0 in 2023.
• Per Business Quant data, the three most recent Gross Profit figures were $1.0 in Q1 2023, -$71537.0 in Q4 2022, and $6592.0 in Q3 2022.